Roche to buy gene therapy specialist Spark in $4.3 billion deal

Roche to buy gene therapy specialist Spark in $4.3 billion deal Roche already sells Hemlibra, a drug against haemophilia A that helps stop bleeding in patients with the life-threatening genetic disorder that prevents their blood from clotting properly.

No comments:

Post a Comment